ClinVar Miner

Submissions for variant NM_007294.3(BRCA1):c.670+16G>A (rs199916228)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV000131335 SCV000186309 likely benign Hereditary cancer-predisposing syndrome 2013-08-03 criteria provided, single submitter clinical testing
GeneDx RCV000444606 SCV000512281 benign not specified 2015-05-07 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Invitae RCV000587845 SCV000560302 benign not provided 2019-03-04 criteria provided, single submitter clinical testing
Department of Pathology and Laboratory Medicine,Sinai Health System RCV000444606 SCV000591292 likely benign not specified 2016-06-29 criteria provided, single submitter clinical testing
Color RCV000131335 SCV000683342 likely benign Hereditary cancer-predisposing syndrome 2017-01-17 criteria provided, single submitter clinical testing
Integrated Genetics/Laboratory Corporation of America RCV000587845 SCV000699285 likely benign not provided 2017-02-13 criteria provided, single submitter clinical testing Variant summary: The BRCA1 c.670+16G>A variant involves the alteration of a non-conserved intronic nucleotide. One in silico tool predicts a benign outcome for this variant. This variant was found in 5/103692 control chromosomes at a frequency of 0.0000482, which does not exceed the estimated maximal expected allele frequency of a pathogenic BRCA1 variant (0.0010005). However, this variant, which is found in 11 patients in the UMD database and 2 families in kConFab, is reported as co-occurring with a pathogenic variant in BRCA2 (c.7795_7797delGAA (p.Glu2599del)). Multiple clinical diagnostic laboratories/reputable databases classified this variant as "likely benign/polymorphysm". Similarly, 4/5 in silico tools (via Alamut) predict that this variant does not affect the normal splicing pattern and in functional studies the variant was shown to increase exon 10 inclusion (Steffensen_EJHG_2014). Taken together, this data strongly support non-pathogenicity, therefore the variant was classified as likely benign.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.